Natasha L. Grimsey

85 Park Road
Grafton, AUK 1023, New Zealand

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Cannabinoid Receptor 2 (CB2) in Macrophages: A Promising Clinical Target for Immune Disorders.

Cannabinoid Receptor 2 (CB2) in Macrophages: A Promising Clinical Target for Immune Disorders.

Journal: International journal of molecular sciences

Published: July 14, 2025

Insights into cannabinoid receptor 2 (CB2) anterograde trafficking and pharmacological chaperoning.

Insights into cannabinoid receptor 2 (CB2) anterograde trafficking and pharmacological chaperoning.

Journal: Cellular and molecular life sciences : CMLS

Published: February 23, 2025

Highlights and hot topics in GPCR research from 'Down Under'.

Highlights and hot topics in GPCR research from 'Down Under'.

Journal: British journal of pharmacology

Published: May 27, 2024

Single nucleotide polymorphisms in the cannabinoid CB2 receptor: Molecular pharmacology and disease associations.

Single nucleotide polymorphisms in the cannabinoid CB2 receptor: Molecular pharmacology and disease associations.

Journal: British journal of pharmacology

Published: November 30, 2023

Evaluating signaling bias for synthetic cannabinoid receptor agonists at the cannabinoid CB2 receptor.

Evaluating signaling bias for synthetic cannabinoid receptor agonists at the cannabinoid CB2 receptor.

Journal: Pharmacology research & perspectives

Published: November 06, 2023

A unique melanocortin-4-receptor signaling profile for obesity-associated constitutively active variants.

A unique melanocortin-4-receptor signaling profile for obesity-associated constitutively active variants.

Journal: Journal of molecular endocrinology

Published: March 08, 2023

Novel Cannabinoid Receptor 2 (CB2) Low Lipophilicity Agonists Produce Distinct cAMP and Arrestin Signalling Kinetics without Bias.

Novel Cannabinoid Receptor 2 (CB2) Low Lipophilicity Agonists Produce Distinct cAMP and Arrestin Signalling Kinetics without Bias.

Journal: International journal of molecular sciences

Published: February 13, 2023

Utilizing PET and MALDI Imaging for Discovery of a Targeted Probe for Brain Endocannabinoid α/β-Hydrolase Domain 6 (ABHD6).

Utilizing PET and MALDI Imaging for Discovery of a Targeted Probe for Brain Endocannabinoid α/β-Hydrolase Domain 6 (ABHD6).

Journal: Journal of medicinal chemistry

Published: December 14, 2022

Cannabinoid CB2 receptor orthologues; in vitro function and perspectives for preclinical to clinical translation.

Cannabinoid CB2 receptor orthologues; in vitro function and perspectives for preclinical to clinical translation.

Journal: British journal of pharmacology

Published: November 08, 2022

RAMP and MRAP accessory proteins have selective effects on expression and signalling of the CB1, CB2, GPR18 and GPR55 cannabinoid receptors.

RAMP and MRAP accessory proteins have selective effects on expression and signalling of the CB1, CB2, GPR18 and GPR55 cannabinoid receptors.

Journal: British journal of pharmacology

Published: September 22, 2022

Developing the Cannabinoid Receptor 2 (CB2) pharmacopoeia: past, present, and future.

Developing the Cannabinoid Receptor 2 (CB2) pharmacopoeia: past, present, and future.

Journal: Trends in pharmacological sciences

Published: February 02, 2022

Cannabinoid receptor CB1 and CB2 interacting proteins: Techniques, progress and perspectives.

Cannabinoid receptor CB1 and CB2 interacting proteins: Techniques, progress and perspectives.

Journal: Methods in cell biology

Published: November 09, 2021

Showing 1-12 of 33

Last Updated: 09/26/2026